Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S127-S132

  Patel, Manish ^a   Pedreira, Cristina ^b   De Oliveira, Lúcia Helena ^b   Tate, Jacqueline ^a   Leshem, Eyal ^a   Mercado, Juan ^c   Umaña, Jazmina ^c   Balmaceda, Angel ^c   Reyes, Martha ^c   Kerin, Tara ^a   McDonald, Sharla ^a   Gentsch, Jon ^a   Bowen, Michael D ^a   Parashar, Umesh ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c Ministerio de Salud   (Nicaragua)

Author keywords

diarrhea; RotaTeq; rotavirus; strains; vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; COHORT ANALYSIS; DRUG EFFICACY; GROUPS BY AGE; HUMAN; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; NICARAGUA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTION; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS; SEROTYPE; TREND STUDY; VACCINATION; VIRUS STRAIN; VIRUS TYPING; CASE CONTROL STUDY; CLASSIFICATION; DEVELOPING COUNTRY; DIARRHEA; DNA SEQUENCE; FECES; FEMALE; GASTROENTERITIS; GENETICS; GENOTYPE; HOSPITALIZED CHILD; IMMUNOLOGY; MALE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; ROTAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; VACCINE IMMUNOGENICITY; VIROLOGY;

CASE-CONTROL STUDIES; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DIARRHEA; FECES; FEMALE; GASTROENTERITIS; GENOTYPE; HUMANS; IMMUNOGENICITY, VACCINE; INFANT; MALE; NICARAGUA; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEQUENCE ANALYSIS, DNA; SEROGROUP; VACCINE POTENCY; VACCINES, ATTENUATED;

EID: 84965155946     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1017     Document Type: Article

References (27)

1. World Health Organization. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009; 84:533-40.
2. do Carmo GM, Yen C, Cortes J, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: A time-series analysis. PLoS Med 2011; 8:e1001024.
3. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362:299-305.
4. Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365:1108-17.
5. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340:c2825.
6. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-51.
7. Patel M, Pedreira C, De Oliveira LH, et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012; 130:e365-72.
8. Clark HF, Offit PA, Ellis RW, et al. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis 1996; 174(suppl 1): S73-80.
9. Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192(suppl 1):S146-59.
10. Espinoza F, Bucardo F, Paniagua M, Svensson L, Hallander HO, Bondeson K. Shifts of rotavirus G and P types in Nicaragua-2001-2003. Pediatr Infect Dis J 2006; 25:1078-80.
11. Khawaja S, Cardellino A, Mast TC. Hospital-based surveillance and analysis of genotype variation in Nicaragua after the introduction of the pentavalent rotavirus vaccine. Pediatr Infect Dis J 2014; 33:e25-8.
12. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2011; 376:606-14.
13. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomised, double-blind, placebo-controlled trial. Lancet 2011; 376:615-23.
14. Das BK, Gentsch JR, Cicirello HG, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 1994; 32:1820-2.
15. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30:1365-73.
16. Freeman MM, Kerin T, Hull J, McCaustland K, Gentsch J. Enhancement of detection and quantification of rotavirus in stool using a modified real-time RT-PCR assay. J Med Virol 2008; 80:1489-96.
17. Esona MD, Steele D, Kerin T, et al. Determination of the G and P types of previously nontypeable rotavirus strains from the African Rotavirus Network, 1996-2004: identification of unusual G types. J Infect Dis 2010; 202(suppl): S49-54.
18. Estes MK, Cohen J. Rotavirus gene structure and function. Microbiol Rev 1989; 53:410-49.
19. Simmonds MK, Armah G, Asmah R, et al. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol 2008; 42:368-73.
20. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276-82.
21. Esona MD, Geyer A, Page N, et al. Genomic characterization of human rotavirus G8 strains from the African rotavirus network: relationship to animal rotaviruses. J Med Virol 2009; 81:937-51.
22. Griffin DD, Fletcher M, Levy ME, et al. Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus. J Infect Dis 2002; 185:1502-5.
23. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63.
24. Vesikari T,MatsonDO, Dennehy P, et al. Safety and efficacy of a pentavalent humanbovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33.
25. Grimwood K, Kirkwood CD. Human rotavirus vaccines: too early for the strain to tell. Lancet 2008; 371:1144-5.
26. Gurgel RQ, Cuevas LE, Vieira SC, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2007; 13:1571-3.
27. Matthijnssens J, Nakagomi O, Kirkwood CD, Ciarlet M, Desselberger U, Van Ranst M. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes? Expert Rev Vaccines 2012; 11:1347-54.